NJ
NJ Addiction Centers
Treatment_types

What Is Dual Diagnosis Treatment?

By NJ Addiction Centers Editorial Team | Last reviewed: | 7 min read Clinically Reviewed

What Is Dual Diagnosis Treatment?

Dual diagnosis treatment is an integrated approach to care that addresses substance use disorders and mental health conditions simultaneously. According to SAMHSA’s National Survey on Drug Use and Health, approximately 9.2 million adults in the United States live with both a mental health disorder and a substance use disorder. When only one condition is treated while the other is ignored, the untreated condition frequently undermines recovery from the treated one. Dual diagnosis programs use coordinated psychiatric and addiction services delivered by a single treatment team to break this cycle.

Key Takeaways

  • Dual diagnosis means a person has both a substance use disorder and a mental health disorder occurring at the same time
  • The terms “dual diagnosis” and “co-occurring disorders” are used interchangeably in clinical practice
  • Integrated treatment that addresses both conditions simultaneously produces better outcomes than treating each condition separately
  • Common co-occurring combinations include depression and alcohol use disorder, PTSD and opioid use disorder, and anxiety disorders with various substances
  • Effective dual diagnosis programs include psychiatric evaluation, medication management, evidence-based therapies like CBT and DBT, and coordinated treatment planning
  • New Jersey has multiple dual diagnosis treatment options across all levels of care

What Is Dual Diagnosis?

Definition and Common Combinations

Dual diagnosis (co-occurring disorders): The simultaneous presence of at least one substance use disorder and at least one mental health disorder in the same individual. Both conditions meet independent diagnostic criteria and each influences the course and treatment of the other.

The relationship between mental health and substance use is bidirectional. Mental health conditions can drive substance use as a form of self-medication. Chronic substance use can trigger or worsen psychiatric symptoms. In many cases, shared neurobiological and environmental factors contribute to both conditions.

The most commonly identified co-occurring combinations include:

  • Depression and alcohol use disorder: One of the most prevalent pairings. Alcohol’s depressant effects worsen depressive symptoms, while depression increases the risk of heavy drinking.
  • PTSD and opioid use disorder: Traumatic experiences can drive opioid use for emotional numbing, while opioid withdrawal intensifies PTSD symptoms.
  • Anxiety disorders and benzodiazepine or alcohol use: Substances that reduce anxiety in the short term create dependence and ultimately worsen anxiety.
  • Bipolar disorder and stimulant or alcohol use: Manic episodes can trigger impulsive substance use; depressive episodes may lead to self-medication.
  • ADHD and stimulant or cannabis use: Untreated ADHD increases substance use risk, particularly for stimulants and cannabis.
  • Borderline personality disorder and polysubstance use: Emotional dysregulation drives substance use as a coping mechanism.

Dual Diagnosis vs. Co-Occurring Disorders

These terms mean the same thing. “Dual diagnosis” was the earlier terminology and remains widely used in popular understanding. “Co-occurring disorders” is the preferred clinical term because it more accurately captures that there may be multiple conditions present, not just two.

In practice, someone with a “dual diagnosis” may have one substance use disorder and multiple mental health conditions (for example, PTSD, depression, and opioid use disorder), or multiple substance use disorders alongside a psychiatric condition.

Why Integrated Treatment Is Essential

The Problem with Treating One Condition Alone

Historically, addiction treatment and mental health treatment operated as separate systems. A person with depression and alcohol use disorder might be told to “get sober first” before addressing depression, or might receive psychiatric medication without any addiction treatment. This siloed approach fails for predictable reasons:

  • Untreated depression or anxiety creates emotional distress that drives return to substance use
  • Untreated substance use disrupts psychiatric medication effectiveness and destabilizes mental health
  • Patients fall through gaps between systems, receiving incomplete care from both
  • Relapse in one condition triggers relapse in the other, creating a revolving door of treatment episodes

Research consistently demonstrates that sequential or parallel treatment (addressing conditions in separate programs or at separate times) produces worse outcomes than integrated treatment. SAMHSA has identified integrated treatment for co-occurring disorders as an evidence-based practice.

How Integrated Programs Work

Integrated dual diagnosis treatment places addiction and mental health clinicians on the same team, treating both conditions within a unified treatment plan. Key elements include:

  • Single treatment team: Addiction counselors, psychiatrists, and therapists collaborate rather than operating independently
  • Unified treatment plan: One plan addresses both conditions with coordinated goals, rather than separate plans that may conflict
  • Concurrent services: Psychiatric medication management happens alongside addiction therapy, not before or after
  • Stage-wise approach: Treatment intensity adjusts based on which condition is more acute at any given point
  • Shared documentation: All providers have access to the full clinical picture, eliminating communication gaps

What Dual Diagnosis Treatment Looks Like

Assessment and Diagnosis

Comprehensive dual diagnosis assessment includes:

  • Psychiatric evaluation: A psychiatrist or psychiatric nurse practitioner conducts a diagnostic assessment for mental health conditions using DSM-5 criteria
  • Substance use assessment: Addiction specialists evaluate the type, severity, and duration of substance use using standardized tools
  • Integrated assessment: Clinicians examine the interaction between conditions: how each affects the other, which symptoms are substance-induced versus independent, and what the treatment priorities are

One clinical challenge is distinguishing substance-induced psychiatric symptoms from independent mental health disorders. For example, cocaine use can produce symptoms that look like bipolar disorder, and heavy alcohol use can mimic clinical depression. Accurate diagnosis may require a period of sobriety before certain psychiatric diagnoses can be confirmed.

Therapeutic Approaches

Effective dual diagnosis programs use evidence-based therapies that address both conditions:

  • Cognitive Behavioral Therapy (CBT): Addresses distorted thinking patterns that maintain both substance use and mental health symptoms. CBT has strong evidence for depression, anxiety, PTSD, and substance use disorders.
  • Dialectical Behavior Therapy (DBT): Particularly effective for patients with emotional dysregulation, borderline personality features, and self-destructive behaviors including substance use. Learn more about DBT therapy.
  • Trauma-informed therapies: EMDR, Seeking Safety, and Cognitive Processing Therapy (CPT) address traumatic experiences that underlie both PTSD and substance use.
  • Motivational Interviewing (MI): Builds motivation for change in both substance use and mental health treatment engagement.
  • Group therapy: Process groups and psychoeducation groups specifically designed for people with co-occurring disorders.

Medication Management

Psychiatric medication is often a critical component of dual diagnosis treatment:

  • Antidepressants: SSRIs (sertraline, fluoxetine) and SNRIs (venlafaxine, duloxetine) for depression and anxiety. These medications are generally safe and non-addictive.
  • Mood stabilizers: Lithium, valproic acid, or lamotrigine for bipolar disorder.
  • Antipsychotics: Atypical antipsychotics for schizophrenia, bipolar disorder, or treatment-resistant depression.
  • Addiction-specific medications: Buprenorphine (Suboxone) or naltrexone (Vivitrol) for opioid use disorder; naltrexone or acamprosate for alcohol use disorder.
  • Careful prescribing: Medications with abuse potential (benzodiazepines, stimulants) require careful risk-benefit analysis in patients with substance use disorders.

Medication management in dual diagnosis treatment requires expertise in both psychiatric pharmacology and addiction medicine. The prescribing provider must understand drug interactions, abuse potential, and how psychiatric medications affect recovery.

Dual Diagnosis Treatment in New Jersey

New Jersey has developed a relatively robust infrastructure for dual diagnosis treatment:

  • Licensing: NJ DMHAS licenses substance use disorder programs, and many licensed programs include dual diagnosis capabilities. Programs with JCAHO or CARF accreditation meet additional quality standards.
  • State resources: The NJ Division of Mental Health and Addiction Services oversees both mental health and addiction services, facilitating integrated approaches at the system level.
  • Medicaid coverage: NJ FamilyCare covers both mental health and addiction treatment services, including dual diagnosis programming.
  • Levels of care: Dual diagnosis treatment is available across all levels of care in NJ, from residential to PHP, IOP, and standard outpatient.

Finding the Right Dual Diagnosis Program

When evaluating dual diagnosis programs, key questions to ask include:

  • Does the program have both licensed addiction counselors and psychiatric prescribers on staff?
  • Is treatment truly integrated (one team, one plan), or are mental health and addiction services separate?
  • What evidence-based therapies are used for co-occurring conditions?
  • How is medication managed, and who provides psychiatric oversight?
  • Does the program conduct comprehensive diagnostic assessments, including assessment for trauma?
  • What is the plan for continued care after the current level of treatment?

For an overview of NJ programs with dual diagnosis capabilities, see our guide to dual diagnosis treatment centers in New Jersey. For information on how insurance covers treatment, including dual diagnosis care, see our insurance resources.

Dual diagnosis treatment addresses the clinical reality that addiction and mental health conditions are deeply intertwined. Treating both simultaneously, with a coordinated team and evidence-based approaches, gives patients the best chance at sustained recovery from both conditions.


This is part of our complete guide to Types of Addiction Treatment.

Looking for treatment options in your area? We can help point you in the right direction. (800) 555-0199 — or request a callback.